Furthermore, JAKi may not effectively inhibit the inflammatory SPP1+ and S100A12+ subpopulations, indicating that alternative strategies, such as TNF or JNK inhibition, might be necessary for comprehensive targeting of all inflammatory macrophage subsets in RA. This evidence concerns the gene S100A12 and rheumatoid arthritis.